- Alachua County
COVID-19 Community Resource Portal
- City of Alachua
- Greater Gainesville Chamber
Updates for businesses impacted during this crisis
- COVID-19 Testing Sites
View COVID-19 Testing Sites
FL Department of Health in Alachua County – 352-334-8810
Call for appointment. No referral required.
First Care of Gainesville – 352-373-2340
4343 W Newberry Rd, Gainesville, FL 32607 Same day appointment required.
Malcom Randall VA Medical Center – 352-376-1611
1601 SW Archer Rd, Gainesville, FL 32608 Appointment and referral required.
North Florida Regional Medical Center – 352-333-4000
6500 Newberry Rd, Gainesville, FL 32605
Labcorp at WALGREENS
A: 7520 W Newberry Rd, Gainesville, FL 32606
B: 3909 NW 13 St, Gainesville, FL 32609.
CVS COVID-19 Testing Site
Call to make an appointment, referral not required.
CareSpot Urgent Care 352-888-4449 (A); 352-240-8000 (M)
More info: rebrand.ly/ccgenglish
Call for Scientific Posters
2021 ACMS Poster Symposium
April 27, 2021 – North Florida Regional Medical Center
Poster Submittal Deadline: March 15, 2021
The Alachua County Medical Society invites all Residents, Medical Students and Fellows to submit a scientific poster at the 4th Annual ACMS Poster Symposium. The symposium is divided into two categories (Basic Research and Clinical Case Reports) and provides young physicians with an opportunity to network and share their significant research and clinical work with colleagues, professors and peers.
Platform Presentation: 50 Projects with the highest scores in advanced judging will be invited to present their posters at the 2021 ACMS Poster Symposium event on Tuesday evening, April 27th from 6:00pm to 8:00pm. At the competition, onsite judges will review and score the posters, selecting the three highest scoring posters to be awarded at the ACMS Annual Meeting in May 11, 2021.
Content and Ethical Considerations: Posters are intended to convey a scientific result and may not contain advertisements for commercial interests, products or services. Volunteer physician members of the ACMS will make final decisions about eligibility. The ACMS reserves the right to deny any application that, in the opinion of the reviewers, is deemed promotional, commercial or unethical. All posters must be approved by their participating medical facility prior to submission (UF Health, UCF or North Florida Regional Medical Center).
The three highest scoring projects will each receive a $500 scholarship from the ACMS and be automatically accepted into the Florida Medical Association 2021 David Paulus Poster Symposium in Orlando Florida, Summer Meeting 2021. To qualify for prizes: author must upload poster by March 1st for advance judging AND be available to present the poster on Tuesday, April 27th during the General Poster Competition at North Florida Regional Medical Center from 6:00 – 8:00pm. The winners will be announced at the end of the evening on April 27th. All Poster Presenters are invited to attend the General Poster Competition event on April 27th. A formal presentation of the awards will be presented to the top three posters at the May 11th ACMS Annual Awards Meeting Dinner. The three winners must also submit their posters in E-format for the FMA poster competition to be held in August 2021, in Orlando, Florida.
Advanced judging: Eligible presentations will be reviewed by a team of Judges based on the following CRITERIA:
On-site Judging: In addition to the above criteria, poster presenters will be available for questions on the night of the symposium and will be evaluated based on the author’s ability to achieve the following:
Competition Poster Specifications: Physical Poster size for NFRMC presentation: 41 inches x 23 inches or a maximum of 36×48”. All posters must be mounted on foam core at the NFRMC presentation.
If the poster is to advance to the FMA State competition, the size must be 40.97” x 23.04” to be submitted electronically. See guidelines below.
E-Poster formatting Guidelines: (for highest scoring posters that are selected to present at the FMA meeting)
Visit the E-posterboards.com website for guidelines and technical support:
The ACMS Poster Symposium is sponsored by:
Published: Sep 8, 2020 By: Doug Bennett
Category: College of Pharmacy, College of Medicine, Department of Medicine
The race to find effective treatments for COVID-19 isn’t just about developing new drugs. University of Florida Health scientists are studying a trio of existing medications known to have broad antiviral activity.
wo of drugs have shown promising results in suppressing the Sars-CoV-2 virus in initial tests on human colon and lung cells that were infected with the coronavirus. The third has shown some antiviral activity but was generally less effective than the other two compounds, the researchers found.
Center for Disease Control and Prevention
No vaccine for COVID-19 is currently available however vaccine trials are in progressexternal icon; The National Institutes of Health recently published guidelines on prophylaxis use, testing, and management of COVID-19 patients. For more information, please visit: National Institutes of Health: Coronavirus Disease 2019 (COVID-19) Treatment Guidelinesexternal icon.
The CDC clinical criteria for considering testing for COVID-19 have been developed based on what is known about COVID-19 and are subject to change as additional information becomes available.
PRIORITIES FOR COVID-19 TESTING
(Nucleic Acid or Antigen)
Persons identified by public health officials or clinicians as high priority
Florida Department of Health Update: 5/5/2020
An antibody test may not be able to show if you have a current infection, because it can take 1-3 weeks after infection to make antibodies. We do not know yet if having antibodies to the virus can protect someone from getting infected with the virus again, or how long that protection might last.
Who should be tested
To learn if you have a current infection, viral tests are used. But not everyone needs this test.
If you test positive or negative for COVID-19, no matter the type of test, you still should take preventive measures to protect yourself and others.